ArticleBritish journal of clinical pharmacology2018

Dipeptidyl peptidase-4 inhibitor use is associated with decreased risk of fracture in patients with type 2 diabetes: a population-based cohort study.

Wen-Hsuan Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.